Orion Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
3,240
-100
| -3% | -$32.6K | 0.4% | 45 |
|
|
2025
Q1 | $902K | Hold |
3,340
| – | – | 0.38% | 47 |
|
|
2024
Q4 | $786K | Sell |
3,340
-85
| -2% | -$20K | 0.35% | 53 |
|
|
2024
Q3 | $942K | Sell |
3,425
-150
| -4% | -$41.3K | 0.46% | 44 |
|
|
2024
Q2 | $869K | Sell |
3,575
-100
| -3% | -$24.3K | 0.46% | 41 |
|
|
2024
Q1 | $549K | Hold |
3,675
| – | – | 0.29% | 65 |
|
|
2023
Q4 | $703K | Hold |
3,675
| – | – | 0.41% | 50 |
|
|
2023
Q3 | $651K | Sell |
3,675
-300
| -8% | -$53.1K | 0.42% | 48 |
|
|
2023
Q2 | $755K | Hold |
3,975
| – | – | 0.5% | 47 |
|
|
2023
Q1 | $796K | Sell |
3,975
-30
| -0.7% | -$6.01K | 0.53% | 40 |
|
|
2022
Q4 | $952K | Sell |
4,005
-170
| -4% | -$40.4K | 0.7% | 32 |
|
|
2022
Q3 | $836K | Sell |
4,175
-1,690
| -29% | -$338K | 0.67% | 36 |
|
|
2022
Q2 | $855K | Sell |
5,865
-700
| -11% | -$102K | 0.66% | 37 |
|
|
2022
Q1 | $1.07M | Sell |
6,565
-100
| -2% | -$16.3K | 0.65% | 37 |
|
|
2021
Q4 | $1.13M | Sell |
6,665
-10
| -0.1% | -$1.7K | 0.64% | 38 |
|
|
2021
Q3 | $1.26M | Hold |
6,675
| – | – | 0.76% | 35 |
|
|
2021
Q2 | $1.13M | Hold |
6,675
| – | – | 0.7% | 38 |
|
|
2021
Q1 | $942K | Hold |
6,675
| – | – | 0.66% | 43 |
|
|
2020
Q4 | $868K | Buy |
+6,675
| New | +$868K | 0.64% | 42 |
|